|1.||Vanhee, Merijn: 3 articles (06/2011 - 08/2010)|
|2.||Costers, Sarah: 3 articles (06/2011 - 08/2010)|
|3.||Van Breedam, Wander: 3 articles (06/2011 - 08/2010)|
|4.||Deng, Fang-Ming: 2 articles (10/2015 - 08/2014)|
|5.||Melamed, Jonathan: 2 articles (10/2015 - 08/2014)|
|6.||Zhou, Ming: 2 articles (10/2015 - 08/2014)|
|7.||Geldhof, Marc: 2 articles (06/2011 - 12/2010)|
|8.||Van Doorsselaere, Jan: 2 articles (12/2010 - 08/2010)|
|9.||Nauwynck, Hans J: 2 articles (12/2010 - 08/2010)|
|10.||Yoo, Dongwan: 2 articles (12/2004 - 12/2004)|
06/01/2011 - "Our results suggest that in Ms6 infection, the correct and programmed timing of lysis is achieved by the combined action of Gp4 and Gp5."
02/01/2010 - "The carboxy-terminal 223 residues of the CD163 molecule are not required for interactions with either the GP2a or the GP4 protein, although these residues are required for conferring susceptibility to PRRSV infection in BHK-21 cells. "
08/01/2010 - "The current study aimed to evaluate the antibody response against this and other epitopes on GP4 to infection of pigs with European-type PRRSV. "
12/01/2010 - "In contrast to these 6 virus variants, the 3 other antibody-escape variants did not contain aa substitutions in the GP4 neutralizing epitope and were still sensitive to neutralization by the GP4-specific mAb. These antibody-escape variants were isolated from pigs that did not contain antibodies against this epitope early in infection. "
08/01/2010 - "This revealed that antibodies against the variable region in GP4 of different virus strains are able to neutralize infection with homologous but not heterologous virus strains."
06/01/2013 - "Validation study using biopsy samples revealed that the relative expression of miR-182-5p was statistically higher in high grade cancer even in same GP4. "
08/01/2014 - "The GS, pathologic stages, total tumor volume, and insignificant tumor rate in RP were not significantly different between the biopsy groups of GS 3+3=6 and GS7miniGP4, whereas those parameters were significantly different between biopsy groups of GS 3+3=6 and GS 3+4=7 with GP4 6% to 50% and between biopsy groups of GS7miniGP4 and GS7 with GP4 6% to 50%. "
08/01/2014 - "The quantity of GP4 in the GS7 biopsy significantly correlated with GS, pathologic stage, and total tumor volume in the corresponding RP. "
08/01/2014 - "The quantity of GP4 was calculated as the percentage of total cancer for GS7 cancer in the biopsy. "
08/01/2014 - "With this modified ISUP Gleason grading system, many Gleason score (GS) 6 cancers by the old grading system are upgraded to GS7 cancers on biopsy diagnosis even with minimal quantity (≤5%) of Gleason pattern 4 (GP4) component (GS7miniGP4). "
|3.||Porcine Reproductive and Respiratory Syndrome (PRRS)
09/01/2008 - "Enhanced immune responses of mice inoculated recombinant adenoviruses expressing GP5 by fusion with GP3 and/or GP4 of PRRS virus."
02/01/2011 - "Porcine reproductive and respiratory syndrome is caused by the PRRS virus (PRRSV), which has six structural proteins (GP2, GP3, GP4, GP5, M and N). "
12/08/2004 - "Using the full-length infectious cDNA clone of North American PRRS isolate P129, the ORF2 and ORF4 genes (which encoded minor structural glycoproteins GP2a/2b and GP4, respectively) were individually deleted from the viral genome. "
|4.||Prostatic Neoplasms (Prostate Cancer)
08/01/2014 - "The clinical significance of minimal quantity (≤5%) of GP4 in biopsies with GS7 prostate cancer needs to be further evaluated, particularly because of its potential impact on clinical decisions between active surveillance versus surgery. "
03/15/2007 - "To investigate the prognostic utility of the proportion of prostate biopsy tissue containing Gleason pattern 4 or 5 (GP4/5) after definitive radiotherapy (RT) for prostate cancer. "
06/01/2013 - "Gleason score 7 (GS7) prostate cancer [tumors with both Gleason patterns 3 (GP3) and 4 (GP4)] portends a significantly more aggressive tumor than Gleason score 6 (GS6). "
06/01/2013 - "To decipher molecular relatedness, we used laser capture microdissection (LCM) and whole-genome amplification (WGA) to separately collect and amplify DNA from adjacent GP3 and GP4 cell populations from 14 cases of GS7 prostate cancer. "
10/01/2015 - "Accurate recognition of Gleason pattern (GP) 4 prostate carcinoma (PCa) on needle biopsy is critical for patient management and prognostication. "
12/01/2001 - "Recent evidence shows that the proportion of poorly differentiated prostate carcinoma (Gleason pattern [GP] 4/5) is a surrogate factor for biochemical failure after radical prostatectomy (RP). "
12/15/2003 - "Primary GP 4 tumors represented an aggressive subset of GS 7 prostate carcinomas. "
12/01/2001 - "Significant differences in HER-2/neu amplification and gain of chromosomes 7, 8, and 17 were detected between GP 4 prostate carcinoma and GP 3. The frequency of aberrations increased with tumor volume. "
12/01/2001 - "All aberrations occurred almost exclusively in GP 4 carcinoma (8 of 8 aneusomies 7, 2 of 2 trisomies 17, 9 of 10 HER-2/neu amplifications, and 5 of 6 aneusomies 8; P < .001). "
|2.||Proteins (Proteins, Gene)
|5.||GP 4 (GP4)
|8.||Complementary DNA (cDNA)
|9.||Viral Envelope Proteins
|2.||Prostatectomy (Retropubic Prostatectomy)